Short-term effects of angiotensin receptor blockers on blood pressure control, and plasma inflammatory and fibrinolytic parameters in patients taking angiotensin-converting enzyme inhibitors
Introduction. Angiotensin-converting enzyme (ACE) inhibitors reduce cardiovascular events in patients with established vascular disease and heart failure (HF). ACE-inhibitors have important effects on fibrinolytic balance, which may be the underlying mechanism for a reduction in cardiovascular event...
Main Authors: | Mehmet Agirbasli, Altug Cincin, Oytun A Baykan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2008-03-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.3317/jraas.2008.004 |
Similar Items
-
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers
by: Neil Poulter, et al.
Published: (2006-06-01) -
The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
by: Myla E. Moretti, et al.
Published: (2012-01-01) -
Angiotensin Converting Enzyme Inhibitor/Angiotensin II Receptor Blockers and Pneumonia risk
by: Chia-Lin Liu, et al.
Published: (2010) -
Combination of aliskiren with angiotensin-converting enzyme-inhibitor and angiotensin receptor blocker — mechanism of action
by: Luis M Ruilope
Published: (2008-03-01) -
Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
by: Hyun Woo Lee, et al.
Published: (2021-03-01)